GlassScriptPhysician profile
Mark Alexander Cyterski
NPI 1801638507
$1,909.15
in general payments reported to CMS, 2019-2025
15 companies · $1,353 in 2025
The $1,353 reported for 2025 was more than what 85% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $556 · 2025: $1,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $439.68 | 2024-2025 | Grafix Pl, Stravix Pl, Renasys Touch |
| Organogenesis INC. | $217.79 | 2024-2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $183.11 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $143.24 | 2025 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $140.61 | 2025 | Na |
| Orthofix Medical, INC. | $118.95 | 2024 | Cervical-Stim, Spinal-Stim |
| Lifenet Health | $118.48 | 2025 | Theragenesis Wound Matrix |
| Averitas Pharma INC. | $106.20 | 2024 | Qutenza |
| Solventum Corporation | $104.49 | 2025 | Prevena, V.A.C. Veraflo |
| Paratek Pharmaceuticals, INC. | $102.35 | 2024 | Nuzyra |
| Tactile Systems Technology INC | $92.00 | 2025 | Flexitouch Plus, Nimbl |
| Stryker Corporation | $60.29 | 2025 | Citrefix, 7 X 23mm Citrelock Implant, Ortholoc 3di |
| Mid-Atlantic Surgical Systems, LLC | $49.20 | 2025 | |
| Xeris Pharmaceuticals, INC. | $16.80 | 2025 | Gvoke Hypopen |
| Novo Nordisk INC | $15.96 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Cyterski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.